Abstract:Background The European CE Mark approval study and the MOMENTUM 3 trial
demonstrated safety and a reduction in hemocompatibility-related adverse
events with use of HeartMate 3 (HM3) device. This single center study
investigated the real-world experience in HM3 patients since FDA
approval. Methods This retrospective, observational study included
patients implanted with the HM3 LVAD as a primary implant between
October 2017-March 2020. Patients were divided into trial group
and postapproval group. Primary endpoi… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.